Singapore markets closed

Relay Therapeutics, Inc. (RLAY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.56+0.78 (+11.50%)
At close: 04:00PM EDT
7.61 +0.05 (+0.66%)
After hours: 07:37PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.78
Open6.72
Bid7.55 x 200
Ask7.58 x 200
Day's range6.72 - 7.59
52-week range5.70 - 13.32
Volume1,436,223
Avg. volume1,246,266
Market cap1.004B
Beta (5Y monthly)1.68
PE ratio (TTM)N/A
EPS (TTM)-2.63
Earnings date06 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est21.96
  • GlobeNewswire

    Relay Therapeutics to Participate in Upcoming Investor Conferences

    CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in two upcoming fireside chats: TD Cowen 5th Annual Oncology Innovation Summit, taking place virtually on Tuesday, May 28, 2024 at 9:30 a.m. ETGoldman Sachs 45th Annual Global Healthcare Conference on Wed

  • GlobeNewswire

    Relay Therapeutics to Host New Program and Platform Event on June 6, 2024

    Company to disclose new programs from existing unnamed pre-clinical pipelineCAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that the company will host a New Program and Platform event on Thursday, June 6, 2024 from 8:00 to 10:00 a.m. ET. During the event, the company will disclose new

  • Simply Wall St.

    Relay Therapeutics First Quarter 2024 Earnings: Beats Expectations

    Relay Therapeutics ( NASDAQ:RLAY ) First Quarter 2024 Results Key Financial Results Revenue: US$10.0m (up by US$9.78m...